-
Gut Dysbiosis Drives Prostate Cancer via NF-κB-IL6-STAT3 Axi
2026-05-09
Zhong et al. (2022) reveal that antibiotic-induced gut dysbiosis accelerates prostate cancer progression and docetaxel resistance through activation of the NF-κB-IL6-STAT3 signaling axis. Their work identifies Proteobacteria enrichment and intratumoral LPS as key drivers, highlighting STAT3 as a mechanistic target with translational implications for cancer biology.
-
Adenosine Triphosphate in Cellular Metabolism Research Workf
2026-05-08
Adenosine triphosphate (ATP) is essential for dissecting metabolic pathways and purinergic signaling in modern biomedical research. This guide delivers stepwise protocols, real-world troubleshooting, and strategic insights—leveraging the latest findings on mitochondrial regulation—to help researchers maximize the value of ATP from APExBIO in advanced experimental systems.
-
CXCL1-CXCR2 Signaling in NTS Microglia Drives Pancreatic Can
2026-05-08
This study reveals that CXCL1-CXCR2 signaling in the nucleus tractus solitarii (NTS) critically mediates microglial activation, driving central sensitization and pain in pancreatic cancer. By dissecting neuroimmune interactions in the brainstem, these findings open new avenues for targeted analgesic strategies in cancer-induced visceral pain.
-
CX-4945 (Silmitasertib): Applied CK2 Inhibition in Bench Res
2026-05-07
CX-4945 (Silmitasertib) enables precise and potent interrogation of CK2-regulated signaling, offering unique advantages for both oncology and virology workflows. This article distills protocol optimizations, troubleshooting strategies, and key insights from recent mechanistic studies—empowering researchers to harness CK2 inhibition for advanced pathway mapping and host-directed antiviral investigations.
-
5-(N,N-dimethyl)-Amiloride Hydrochloride: Selective NHE1 Inh
2026-05-07
5-(N,N-dimethyl)-Amiloride hydrochloride is a potent, selective inhibitor of Na+/H+ exchanger isoforms NHE1-3, widely used in ion transport and intracellular pH regulation research. Its robust activity profile and benchmarked selectivity enable reliable modeling of ischemia-reperfusion injury protection and cardiac contractile dysfunction. APExBIO provides this compound as SKU C3505 for research use only.
-
GSK-923295 and Mitotic Fidelity: Advanced Insights for CENP-
2026-05-06
Discover how GSK-923295, a potent CENP-E inhibitor, advances cancer research through precise modulation of mitotic fidelity. This in-depth analysis integrates recent findings on centromere biology with actionable guidance for next-generation assay design.
-
G418 Sulfate: Precision Selection and Antiviral Innovation
2026-05-06
Geneticin (G-418 Sulfate) from APExBIO enables robust, selective cell line development and streamlined antiviral workflows, thanks to its validated ribosome-targeting mechanism. Discover how this gold-standard antibiotic empowers reproducibility, efficiency, and cutting-edge research across genetic engineering and virology.
-
Luminescent ATP Cell Viability Assay I: Precision in Cytosta
2026-05-05
Discover how the Luminescent ATP Cell Viability Assay Kit I enables ultra-sensitive, rapid cell viability measurement for advanced cytostatic and metabolic profiling. Go beyond ferroptosis to explore novel assay strategies, with unique insights from recent glioblastoma research.
-
Budesonide in High-Throughput Permeability Models: Innovatio
2026-05-05
Explore the unique anti-inflammatory properties of Budesonide in the context of advanced, high-throughput permeability modeling. This article uncovers how cutting-edge biomimetic analytical methods transform the use of Budesonide in respiratory disease research, offering insights distinct from existing literature.
-
GKT137831: Dual Nox1/Nox4 Inhibition Unveiled for Advanced O
2026-05-04
Discover how GKT137831, a dual NADPH oxidase Nox1/Nox4 inhibitor, empowers researchers to dissect oxidative stress and ferroptosis. This article uniquely integrates emerging membrane biology insights with advanced protocol guidance.
-
Remdesivir (GS-5734): Structural Insights for Antiviral Inno
2026-05-04
Explore the advanced structural basis of Remdesivir (GS-5734) as a potent antiviral agent. This analysis uniquely bridges molecular mechanism, polymerase complex structure, and assay design for coronavirus and Ebola research.
-
Metformin-Induced Vasorelaxation in Colitis: Novel EDH Mecha
2026-05-03
This paper uncovers how metformin induces vasorelaxation in mesenteric arterioles primarily through endothelium-dependent hyperpolarization (EDH), protecting intestinal microvasculature in murine colitis. The study provides mechanistic evidence that metformin rescues impaired acetylcholine-mediated vasorelaxation, offering new insight into its potential therapeutic use in ulcerative colitis and microvascular dysfunction.
-
NADH Applications: Advanced Protocols & Solutions for Metabo
2026-05-02
NADH is pivotal for unraveling mitochondrial electron transport chain dynamics and powering next-generation photocatalytic cancer therapy. This guide details practical workflows, experimental troubleshooting, and the innovative leverage of reduced nicotinamide adenine dinucleotide in metabolic and translational research.
-
Antimycin A4: Advanced ATP-Citrate Lyase Inhibitor Workflows
2026-05-01
Antimycin A4 uniquely enables simultaneous interrogation of fatty acid biosynthesis and mitochondrial energy metabolism. This guide delivers actionable workflows, protocol optimizations, and troubleshooting insights for researchers leveraging APExBIO’s high-purity ATP-citrate lyase inhibitor in translational and metabolic studies.
-
ATP Beyond Energy: Mechanistic Insight for Translational Res
2026-05-01
This thought-leadership article explores adenosine triphosphate (ATP) as more than the universal energy carrier, integrating new mechanistic findings in mitochondrial proteostasis and post-translational regulation. By bridging basic metabolic control with translational opportunities, we offer actionable guidance for researchers leveraging high-purity ATP from APExBIO.